McDowell Bryan, Dumais Kelly M, Gary Sarah T, Doll Helen A, Nagrani Gauri, Ward Tomás, Muehlhausen Willie
Clario, Philadelphia, PA, USA.
Clario, Philadelphia, PA, USA.
Value Health. 2025 Feb;28(2):269-274. doi: 10.1016/j.jval.2024.10.3801. Epub 2024 Oct 28.
Diversity and inclusion in clinical trials remains an important topic, particularly for participants with disabilities such as vision impairment. With advances in smartphone and tablet technologies and their increasing use in clinical trials, accessibility features, such as pinch to zoom, are now at our fingertips. However, implementing such accessibility features when collecting electronic clinical outcomes assessments (eCOA) does not come without risks and must be designed with careful consideration and scientifically tested to ensure no impact to data integrity. Therefore, the objectives of this study were to determine the measurement equivalence of an eCOA questionnaire with and without a zoom accessibility feature and test its usability.
An eCOA app with a zoom accessibility feature was designed following industry standards for eCOA best design. Participants (n = 53) with chronic or recent pain completed a questionnaire with standard response scales (verbal rating scale, numerical rating scale, and visual analog scale), with and without the zoom accessibility feature enabled, in a randomized crossover design. Intraclass correlation coefficients were determined. A subset of participants (n = 10) with vision impairment participated in a usability testing interview.
The intraclass correlation coefficients analysis showed high agreement (0.894-0.982) between zoomed and non-zoomed completions of the verbal rating scale, numerical rating scale, and visual analog scale. Participant usability testing showed good ease of use, ability to read the screen, and usefulness of the zoom feature, especially when not wearing corrective measures for vision impairment.
These findings support the use of a specially designed eCOA zoom accessibility feature for use in clinical trials.
临床试验中的多样性和包容性仍然是一个重要话题,特别是对于视力障碍等残疾参与者而言。随着智能手机和平板电脑技术的进步以及它们在临床试验中的使用日益增加,诸如捏合缩放等无障碍功能现在触手可及。然而,在收集电子临床结局评估(eCOA)时实施此类无障碍功能并非没有风险,必须经过仔细考虑和科学测试来设计,以确保不会影响数据完整性。因此,本研究的目的是确定具有和不具有缩放无障碍功能的eCOA问卷的测量等效性,并测试其可用性。
按照eCOA最佳设计的行业标准设计了一个具有缩放无障碍功能的eCOA应用程序。患有慢性或近期疼痛的参与者(n = 53)在随机交叉设计中完成了一份具有标准反应量表(语言评定量表、数字评定量表和视觉模拟量表)的问卷,分别在启用和未启用缩放无障碍功能的情况下进行。确定组内相关系数。一部分有视力障碍的参与者(n = 10)参加了可用性测试访谈。
组内相关系数分析显示,语言评定量表、数字评定量表和视觉模拟量表在缩放和未缩放完成情况之间具有高度一致性(0.894 - 0.982)。参与者可用性测试表明,该应用程序易于使用、屏幕可读性良好,缩放功能很有用,尤其是在未采取视力障碍矫正措施时。
这些发现支持在临床试验中使用专门设计的eCOA缩放无障碍功能。